Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials

INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for treatment of type 2 diabetes mellitus; however, there have been concerns that GLP-1RA treatment may be associated with an increased incidence of pancreatitis. This study aimed to evaluate the incidence of pancreat...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Marion L., Johnsson, Kristina, Hardy, Elise, Wang, Hui, Iqbal, Nayyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612359/
https://www.ncbi.nlm.nih.gov/pubmed/31077072
http://dx.doi.org/10.1007/s13300-019-0627-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612359/
https://www.ncbi.nlm.nih.gov/pubmed/31077072
http://dx.doi.org/10.1007/s13300-019-0627-1

Ejemplares similares